A Versatile Conformational Switch Regulates Reactivity in Human Branched-Chain α-Ketoacid Dehydrogenase  by Machius, Mischa et al.
Structure 14, 287–298, February 2006 ª2006 Elsevier Ltd All rights reserved DOI 10.1016/j.str.2005.10.009A Versatile Conformational Switch Regulates
Reactivity in Human Branched-Chain
a-Ketoacid DehydrogenaseMischa Machius,1,* R. Max Wynn,1,2
Jacinta L. Chuang,1 Jun Li,1 Ronald Kluger,3
Daria Yu,3 Diana R. Tomchick,1 Chad A. Brautigam,1
and David T. Chuang1,2,*
1Department of Biochemistry
2Department of Internal Medicine
University of Texas Southwestern Medical Center
5323 Harry Hines Boulevard
Dallas, Texas 75390
3Department of Chemistry
University of Toronto
Toronto, Ontario M5S 1A1
Canada
Summary
The dehydrogenase/decarboxylase (E1b) component
of the 4 MD human branched-chain a-ketoacid dehy-
drogenase complex (BCKDC) is a thiamin diphosphate
(ThDP)-dependent enzyme. We have determined the
crystal structures of E1b with ThDP bound intermedi-
ates after decarboxylation of a-ketoacids. We show
that a key tyrosine residue in the E1b active site func-
tions as a conformational switch to reduce the reactiv-
ity of the ThDP cofactor through interactions with its
thiazolium ring. The intermediates do not assume the
often-postulated enamine state, but likely a carbanion
state. The carbanion presumably facilitates the sec-
ond E1b-catalyzed reaction, involving the transfer of
an acyl moiety from the intermediate to a lipoic acid
prosthetic group in the transacylase (E2b) component
of the BCKDC. The tyrosine switch further remodels an
E1b loop region to promote E1b binding to E2b. Our re-
sults illustrate the versatility of the tyrosine switch in
coordinating the catalytic events in E1b by modulating
the reactivity of reaction intermediates.
Introduction
The mitochondrial branched-chain a-ketoacid dehydro-
genase complex (BCKDC), pyruvate dehydrogenase
complex (PDC), and a-ketoglutarate dehydrogenase
complex (KGDC) (Reed et al., 1985) are a family of highly
conserved macromolecular catalytic machines. They
catalyze the oxidative decarboxylation of different a-
ketoacids (Reaction 1) and channel the resulting acyl
moieties into the Krebs cycle in the form of their coen-
zyme A (CoA) derivatives (Chuang and Shih, 2001).
R-CO-COOH + CoA-SH + NAD+
/R-CO-S-CoA + CO2 + NADH + H
+ ð1Þ
Defects in these complexes in humans often produce
severe clinical consequences, e.g., Maple Syrup Urine
Disease (in the case of BCKDC [Chuang and Shih,
*Correspondence: mischa.machius@utsouthwestern.edu (M.M.);
david.chuang@utsouthwestern.edu (D.T.C.)2001]) and primary lactic acidosis (in the case of PDC
[Robinson and Sherwood, 1984]).
The BCKDC is organized around a cubic core made up
of 24 lipoyl-bearing dihydrolipoyl transacylase (E2b)
subunits. Multiple copies of branched-chain a-ketoacid
decarboxylase/dehydrogenase (E1b) and dihydrolipoa-
mide dehydrogenase (E3) are attached to this core to
form a 4 MD multienzyme complex (Reed et al., 1985).
The activity of the BCKDC in eukaryotes is regulated by
phosphorylation and dephosphorylation through the
BCKD kinase (Popov et al., 1992) and the BCKD phos-
phatase (Damuni et al., 1984). The E1b and E2b compo-
nents as well as the kinase and the phosphatase are
specific to the BCKDC, whereas the E3 component is
common among the three a-ketoacid dehydrogenase
complexes (Reed et al., 1985).
E1bs contain thiamine diphosphate (ThDP, the biolog-
ically active form of vitamin B1) and are responsible for
the catalysis of two sequential half reactions (Figure 1)
(Jordan, 2003). First, the decarboxylation of branched-
chain a-ketoacids (BCKAs) derived from the amino acids
leucine, isoleucine, and valine yields covalent ThDP-acyl
intermediates (Reaction 2 [Chuang and Shih, 2001; Reed
et al., 1985]).
R-CO-COOH + ThDP-E1b/R-COH = ThDP-E1b + CO2
(2)
These intermediates, as well as those in the related
E1ps and ThDP-dependent decarboxylases, such as
pyruvate decarboxylase and benzoylformate decarbox-
ylase, are commonly depicted as a resonance hybrid
between an enamine state and an a-carbanion state
(Jordan, 2003) (Figure 1). In the second half reaction cat-
alyzed by E1b, the lipoyl-bearing domain (LBD) of an
E2b subunit binds near the E1b active site, and the
acyl moiety in the intermediate is transferred to the lipoyl
moiety (lipS2), forming an S-acyldihydrolipoamide (E2b-
[R-CO-S-lipSH]) (reductive acylation, Reaction 3).
R-COH = ThDP-E1b + E2b-½lipS2
/½R-CO-S-lipSH-E2b + E1b-ThDP (3)
By contrast, in decarboxylases, the intermediate is
protonated by an acidic residue in the active site to yield
the respective aldehyde as the reaction product. E1 en-
zymes do not seem to possess such an acidic residue,
and the formation of the aldehyde is not a significant
side reaction.
The LBD subsequently delivers the S-acyldihydroli-
poamide to the active site in the E2b core subunit, where
the acyl moiety is transferred to CoA, yielding a final
product of R-CO-SCoA (see Reaction 1). The BCKDC re-
action cycle is then completed by the E3 component,
which utilizes its tightly bound FAD moiety to reoxidize
the dihydrolipoyl moiety on E2b, with NAD+ serving as
the ultimate electron acceptor.
Eukaryotic E1bs are heterotetrameric enzymes con-
sisting of two a (termed a and a0) and two b (termed
b and b0) subunits (Aevarsson et al., 2000). The two
Structure
288Figure 1. General Reaction Scheme for the
Decarboxylation of a-Keto Acids by E1 En-
zymes
The reaction scheme was adapted from Na-
kai et al. (2004). B, general base; AP, amino-
pyrimidine ring; TZ, thiazolium ring; E2-LBD,
lipoic acid binding domain from the BCKDC
E2 subunit; the branched chain of the Ca
atom in the substrate is marked with a straight
arrow.active sites are located at the interfaces between the
a and b0 subunits and the a0 and b subunits (Figure 2).
The ThDP cofactor is situated close to the surface of
the a subunits, with residues from both subunits contrib-
uting to ThDP binding. ThDP-dependent catalysis has
been studied for decades, yet an understanding of the
reaction mechanisms is only now developing. It is estab-
lished that ThDP must first be activated to become
a useful cofactor (Breslow, 1957). Enzymes activate
ThDP by geometric and electronic distortion, which ulti-
mately leads to the abstraction of the proton on the C2
carbon atom in the thiazolium ring by the N40-amino
group in the aminopyrimidine ring of ThDP (Kern et al.,
1997). The resulting ylide with its negatively charged
C2 carbon is believed to be the primary reactive stateof ThDP that subsequently attacks a carbonyl carbon
in a substrate molecule.
In human E1b, the S1/C2 side of the thiazolium ring in
ThDP is facing a large cavity lined by residues Phe85-a,
Met87-a, Gln112-a, Ser162-a, His291-a, Ser292-a,
Val148-a, His149-a, Tyr102-b0, and His146-b0 (Figure 2).
This cavity is partially occupied by the side chain of
Tyr113-a, with the hydroxyl group pointing toward the lo-
cation in which substrate molecules bind (referred to
herein as the ‘‘S’’ conformation). In the absence of an
a-ketoacid substrate, the side chains of Tyr113-a and
the neighboring Gln112-a, one of the ligands of a potas-
sium ion in thea subunit, appear to be somewhat flexible,
as indicated by weak electron density (Wynn et al., 2003).
In this state, Tyr113-a can also exist in a second, muchFigure 2. Stereoview of the Active Site in
hE1b and Surrounding Regions
PDB accession code, 1OLS. Carbon atoms
from the a subunit are in gray, those from
the b0 subunit are in light orange, and those
from the ThDP cofactor are in green. The cen-
tral Tyr113-a is shown in cyan in the two con-
formations that it is observed in, denoted ‘‘S’’
and ‘‘P.’’ In the much higher populated S con-
formation, the side chain points into the sub-
strate binding cavity. In the P conformation,
the side chain interacts with the phosphates
of the ThDP cofactor. The phosphorylation
loop containing Ser292-a, whose phosphory-
lation is sufficient to deactivate hE1b, is
shown in purple. The phosphorylation loop
is presumed to take part in the formation of
the LBD binding region. Oxygen atoms are in
red, nitrogen is in blue, sulfur and potassium
are in yellow, phosphorous is in purple, and
manganese is in cyan. Figures 2, 3, 5, and 7
and Figure S1 were generated with BobScript
(Esnouf, 1999) and rendered with POV-Ray
(www.povray.org).
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289less populated conformation in which the hydroxyl group
interacts with the ThDP phosphate groups (referred to
here as the ‘‘P’’ conformation). It should be noted that
in the presence of competitive inhibitors such as clofi-
brate or 2-chloroisocaproate, Tyr113-a exclusively
adopts the P conformation (Aevarsson et al., 2000), pre-
sumably because their binding to the substrate binding
cavity blocks access of Tyr113-a to the S conformation.
A water molecule (Wat1 in Figure 2) is located in the sub-
strate binding site within hydrogen bonding distance to
the hydroxyl group of Tyr113-a and the side chain of
His146-b0. The side chain of His291-a, which has been
shown to be important for ThDP binding to hE1b (Wynn
et al., 2003), is located opposite of His146-b0. His291-a
interacts with the ThDP phosphate groups through water-
mediated hydrogen bonds. This residue and the follow-
ing Ser292-a belong to the phosphorylation loop (resi-
dues 285–313-a). Phosphorylation of this serine residue
is sufficient to deactivate hE1b (Sugden and Randle,
1978; Zhao et al., 1994). The phosphorylation loop, which
exhibits considerable flexibility and is partially disor-
dered (Li et al., 2004; Wynn et al., 2003), participates in
forming the lipoyl-access channel. LBD binds in this re-
gion, inserting its lipoyl moiety in order to extract the sub-
strate acyl chain during reductive acylation. No direct
structural information is available on the binding of
LBD to E1 enzymes. A model has been proposed for
the attack of the lipoamide carried by LBD on a ThDP
bound intermediate following the decarboxylation reac-
tion intermediate (Aevarsson et al., 1999). According to
this model, LBD binding prior to the formation of a decar-
boxylation intermediate would sterically interfere with
the binding and decarboxylation of substrates. It is
therefore likely that the two E1b-catalyzed half reactions
are efficiently coordinated in its active site.
In this study, we elucidate the regulation of the chem-
ical events within the active site of human E1b. We dem-
onstrate that a highly conserved tyrosine residue,
Tyr113-a, by switching between two conformational
states, is responsible for modulating the reactivity of
the ThDP cofactor. The Tyr113-a side chain blocks the
substrate binding cavity adjacent to the ThDP cofactor,
which appears to be in a hyperreactive state. Binding
of a substrate a-ketoacid molecule displaces the ty-
rosine side chain; thus, a different conformation is
adopted where it contacts the ThDP thiazolium ring, and
a concomitant reduction in the reactivity of the cofactor
is seen. The crystal structures of postdecarboxylation in-
termediates disclose that the intermediates are severely
distorted from planarity. These ThDP bound intermedi-
ates thus exist in a carbanion state, rather than an en-
amine state, presumably resulting in an increased reac-
tivity for the subsequent acyl transfer to the lipoyl
moiety on LBD. The tyrosine switch in the presence of
the ThDP bound intermediate furthermore leads to the
stabilization of the putative LBD binding region to in-
crease its affinity for LBD and therefore acts as an indica-
tor for the state of the active site. This signaling mecha-
nism appears to be able to coordinate the order of the
catalytic events in the BCKDC. These features provide
an illustrative case in which subtle conformational
changes in the side chain of a single residue in the active
site are capable of regulating diverse catalytic aspects of
an enzyme.Results and Discussion
Structural Features of Postdecarboxylation
Reaction Intermediates
When crystals of wild-type hE1b are incubated with the
natural substrates a-ketoisocaproic acid (KIC), a-ketoi-
sovaleric acid (KIV), and a-keto-b-methylvaleric acid
(KMV), electron densities appear in the active site that
correspond to the respective reaction intermediates
after decarboxylation (Figure 3 and Figure S1; see the
Supplemental Data available with this article online).
The decarboxylation reaction occurs quickly in our
crystals, as demonstrated by a short (2 min) exposure
of a crystal to KIC prior to flash cooling to about
2196ºC, which resulted in a similar occupancy of the
intermediate state as in a crystal soaked for 24 hr
(data not shown). Crystallographic data are presented
in Table 1.
Despite the fact that the different substrates have
branched-chain moieties of varying sizes, the substrate
binding cavity does not undergo large structural adapta-
tions upon formation of the decarboxylation reaction in-
termediate. The sole, but important, exception is Tyr113-
a. In the presence of a reaction intermediate, the side
chain of Tyr113-a is locked in place at the diphosphate
end of ThDP (Figure 3). In this P conformation, the
Tyr113-a OH group is located below and to the side of
the thiazolium ring. The hydroxyl group establishes inter-
actions with the terminal ThDP phosphate group (dis-
tance of about 2.6 A˚) as well as with the sulfur atom in
the thiazolium ring (distance of about 2.9 A˚). It is impor-
tant to note that the interaction with the sulfur atom is
out of the plane of the thiazolium ring. The P state is fur-
ther characterized by a structural change of Gln112-a,
which is pulled away from coordinating the nearby po-
tassium ion and now also contacts the ThDP phosphate
groups. Although the P conformation for Tyr113-a is
populated to a small extent in the absence of sub-
strate/intermediates, the P conformation for Gln112-
a is only observed when an intermediate is present.
Tyr113-a is highly conserved in E1 components from eu-
karyotic PDCs and BCKDCs as well as PDCs of the het-
erotetrameric type from gram-positive bacteria (Fig-
ure 4). An equivalent residue is not present in KDGC E1
components, because they are of homodimeric type
with different sequence signatures for the active site. It
should be noted that, in contrast to hE1b, in Thermus
thermophilus E1b (tE1b), Tyr95-a, which is equivalent
to Tyr113-a in hE1b, was found to adopt the P conforma-
tion in the absence of substrate (Nakai et al., 2004). Care-
ful examination of the electron density (PDB code 1UMB)
reveals large features in the substrate binding site that
the authors interpreted as water molecules. Based on
the characteristics of these features, there is a possibility
that they represent an unidentified ligand. The presence
of a ligand in the substrate binding cavity would prevent
Tyr95-a from adopting the S conformation. It is therefore
possible that the central tyrosine in tE1b also exists pre-
dominantly in the S conformation in the absence of sub-
strate and that it undergoes a similar S-to-P transition
upon substrate binding to that observed in hE1b. Further
studies are required to address this issue.
At the resolution observed for our X-ray diffraction
data (1.79–1.88 A˚), the electron densities allow the
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290Figure 3. Structure and 2Fo 2 Fc Electron
Density for Decarboxylation Products in hE1b
(A–C) Electron density (shown in blue) is con-
toured at 1.2 s. The view for the figures on the
left side is along the S-C2 bond in the thiazo-
lium ring (edge-on) as observed for ThDP in
hE1b in the absence of a reaction intermedi-
ate. The view was chosen to emphasize devi-
ations from planarity in the intermediates: if
the intermediate existed in an enamine state,
the atoms belonging to the thiazolium ring as
well as the Ca and Cb carbon atoms in the in-
termediate would need to lie on one line. The
diphosphate moiety has been omitted for
clarity. The figures on the right side are ro-
tated by about 90º around the horizontal
axis compared to those on the left side. (A)
2-(a-hydroxy-isopentyl)-ThDP (CThDP), the
intermediate from a-ketoisocaproate (KIC),
(B) 2-(a-hydroxy-phenyl)-ThDP (BThDP), the
intermediate from benzoylformate (BF), (C)
ThDP in the absence of a reaction intermedi-
ate (for comparison). A similar figure for 2-(a-
hydroxy-isobutyl)-ThDP (VThDP), the inter-
mediate from a-ketoisovalerate (KIV), and
2-(a-hydroxy-b-methylbutyl)-ThDP (MThDP),
the intermediate from a-keto-b-methylvaler-
ate (KMV) is provided in the Supplemental
Data. The S and P conformations of Tyr113-a
are indicated. Important atoms are marked
with arrowheads (thiazolium C4A methyl
group, black; thiazolium C2 carbon, blue; in-
termediate Ca carbon, red; intermediate Cb
carbon, cyan). Important interactions are
shown as dotted lines. Carbon atoms from
the hE1b-a subunit are in gray, those from the
b subunit are in pink, and those from ThDP
are in green. Oxygen atoms are in red, nitro-
gen is in blue, sulfur is in yellow, phosphorous
is in purple, and manganese is in cyan. AP,
aminopyrimidine ring; TZ, thiazolium ring.identification of several characteristic and unexpected
structural features in the intermediates. First, it appears
as if the thiazolium ring in the decarboxylation interme-
diates is not entirely planar. In all intermediates studied,
the thiazolium sulfur atom seems to move slightly out of
the ring plane toward the hydroxyl oxygen of Tyr113-a.
In addition, the C4A methyl group is slightly above the
plane in all ThDP variants described in this study. As
a consequence, the entire ring adopts a somewhat ruf-
fled conformation. For rms deviations from planarity
for the thiazolium ring and the directly bonded atoms
(C35, C4A, C5A, and Ca; Figure 1), see Table 1. At pres-
ent, the question of whether these deviations are signif-icant cannot be reliably answered, because much
higher-resolution data would be required.
Strikingly, the bond between the thiazolium C2 carbon
and the substrate Ca carbon atom has a distinct, angled
orientation, out-of-plane compared to the thiazolium
ring by as much as about 16º in the intermediate ob-
tained from KIC (Figure 3A). Its length is between 1.48
and 1.55 A˚ in the different intermediates and thus indi-
cates that it is a single bond.
Finally, the configuration around the Ca carbon is not
planar, as either the Ca-oxygen bond and/or the Ca-Cb
bond is out-of-plane with respect to the thiazolium ring
(Figure 3 and Figure S1). The oxygen is in hydrogen
Conformational Switch in Human E1b
291Table 1. Data Collection and Refinement Statistics
Sample
Mutation — — — — Q112A Y113F —
Intermediate CThDP VThDP MThDP BThDP — ThTDP ThTDP
SBDa — — — — Yes Yes Yes
Data Collection
Space group P3121 P3121 P3121 P3121 P3121 P3121 P3121
Unit cell dimensions,
a = b; c
145.04; 69.51 145.79; 69.52 144.47; 69.48 144.56; 69.49 145.78; 69.37 145.34; 69.19 145.13; 69.35
Resolution (A˚)b 22.83–1.84
(1.87–1.84)
25.61–1.88
(1.91–1.88)
32.05–1.80
(1.83–1.80)
36.14–1.79
(1.82–1.79)
26.76–1.77
(1.80–1.77)
35.88–1.64
(1.67–1.64)
21.51–1.46
(1.49–1.46)
Completenessb 97.3 (80.8) 95.4 (99.8) 100.0 (100.0) 98.9 (79.1) 99.7 (99.9) 97.8 (79.4) 98.8 (84.4)
Rmerge (%)
b 7.8 (73.0) 9.9 (67.1) 7.9 (61.3) 6.7 (40.0) 9.0 (73.7) 4.8 (44.3) 3.8 (41.1)
I/s(I)b 22.5 (1.9) 17.3 (2.2) 21.7 (3.0) 25.3 (2.7) 19.4 (2.0) 30.9 (2.4) 36.5 (2.0)
Multiplicityb 6.0 (5.2) 6.0 (5.5) 6.0 (5.8) 6.0 (3.9) 6.5 (4.4) 5.4 (4.1) 5.3 (2.9)
Wilson B factor (A˚2) 18.23 22.65 15.20 16.17 18.88 16.08 15.63
Refinement
Resolution (A˚) 22.83–1.84 25.61–1.88 30.00–1.80 30.00–1.79 26.76–1.77 30.00–1.64 21.51–1.46
Number of reflections,
Rwork/Rfree
69,564/1,477 63,749/1,527 75,773/1,441 76,446/1,455 81,272/1,455 99,084/1,493 142,000/1,436
Rwork/Rfree (%) 14.79/18.75 17.03/21.15 13.86/16.98 14.62/17.03 14.46/18.41 14.37/15.86 14.95/16.57
Average B factor (A˚2) 18.29 17.14 13.26 23.25 17.05 15.47 13.23
Rms deviations
Bond lengths (A˚) 0.020 0.020 0.020 0.021 0.019 0.020 0.020
Angles (º) 1.662 1.727 1.667 1.882 1.672 1.920 1.911
Thiazolium ring
plane (A˚)c
0.099 (8.3) 0.027 (2.3) 0.038 (3.2) 0.065 (5.4) 0.017 0.027 0.047
DPI (A˚)d 0.107 0.127 0.090 0.089 0.091 0.067 0.053
Ramachandran plot
(allowed/add./
gen./dis.)e
91.1/8.2/0.3/0.3 90.2/8.8/0.3/0.6 90.7/8.8/0.2/0.3 91.2/8.3/0.2/0.3 91.7/7.8/0.2/0.3 91.0/8.5/0.2/0.3 91.0/8.5/0.2/0.3
a Crystal form with SBD present.
b Numbers in brackets refer to the highest-resolution shell.
c Numbers in brackets are the rms deviations normalized against the rms deviation (0.012 A˚) of the thiazolium ring in ThDP of hE1b in the absence
of an intermediate (PDB entry 1OLS); values were calculated as described in Experimental Procedures.
d Average coordinate errors as expressed through the Cruickshank diffraction-component precision index (DPI) (Cruickshank, 1999).
e add., additional allowed regions; gen., generously allowed regions; dis., disallowed regions.bonding distance to the N40 nitrogen atom of ThDP and
the side chains of Tyr102-b0 and His146-b0.
The extent of the nonplanarity around the C2 and Ca
carbons varies with the substrate used; the decarboxyl-
ation intermediate from KIC and KMV shows very pro-
nounced deviations, and the intermediate derived from
KIV is nearly planar. The intermediate derived from ben-
Figure 4. Partial Sequence Alignment of E1b and E1p Enzymes from
Various Organisms
Strictly conserved residues are highlighted in red, conserved resi-
dues are highlighted in yellow. Tyr133-a in hE1b is marked with
a red triangle. The secondary structures indicated at the top are
those in hE1b. h, Homo sapiens; b, Bos taurus; r, Rattus norvegicus;
p, Pseudomonas putida; t, Thermus thermophilus; a, Ascaris suum;
s,Saccharomyces cerevisiae; g,Geobacillus subtilis; m,Mycobacte-
rium genitalium. TT, tight turn. The alignment was created with
CLUSTALW (Thompson et al., 1994), and the figure was created
with ESPRIPT (Gouet et al., 2003).zoylformate shows the most nonplanar configuration
around the Ca atom (Figure 3B). Benzoylformate is not
a natural substrate for hE1b (as it is for benzoylformate
decarboxylase) (Hasson et al., 1998), but it is readily de-
carboxylated by hE1b. However, the resulting intermedi-
ate is unreactive in the second catalytic step (reductive
acylation) and is therefore a suicide inhibitor for BCKDC.
The electron density shows that the Ca-oxygen bond is
in hydrogen bonding distance only to His146-b0 and a wa-
ter molecule, but no longer to Y102-b0, nor to the 40 nitro-
gen atom of ThDP. The terminal phenyl ring in the inter-
mediate is wedged between the rings of Tyr113-a,
Phe85-a, and His146-b0 with contacts closer than 3.4 A˚.
This distance is short for van der Waals interactions
and likely leads to additional strain on this intermediate,
which likely explains the more drastic distortions of this
intermediate compared to other intermediates. These
distortions and/or steric hindrance by the phenyl ring
may be responsible for rendering BThDP inactive in the
second reaction catalyzed by hE1b.
Postdecarboxylation Reaction Intermediates Do Not
Adopt an Enamine State
The intermediate state observed in hE1b is incompatible
with an enamine structure. The enamine state would re-
quire all thiazolium ring atoms and the intermediate Ca
Structure
292Table 2. Kinetic Properties of hE1b and hE1p Proteins
Variant
Decarboxylationa
Decarboxylationb LBD Binding Reductive Acylation
KM [mM] kcat [min
21] kcat/KM [min
21mM21] kcat [min
21] Kd [mM] kcat [s
21]
hE1b wild type 55 6 2 11.9 6 2 0.24 4.8 15.6 10.2
hE1b Y113F-a 73 6 3 171 6 13 2.34 54.1 21.4 38.3
hE1b-BFc 60 6 3 4.2 6 3 0.07 na 0.35 0
hE1p wild type 21 6 3 18 6 3 0.85 na na na
hE1p Y89F-a 31 6 5 163 6 11 5.3 na na na
na, not determined.
a Using KIV (in the case of E1b proteins) or pyruvate (in the case of E1p proteins) as a variable substrate and monitoring DCPIP reduction.
b Using KIV as a variable substrate and monitoring CO2 evolution in the absence of DCPIP.
c Wild-type hE1b reacted with benzoylformate.atom, as well as all atoms directly bonded to them, to lie
on one plane. Although nonplanar, the Ca-carbon atom
does not assume a tetrahedral sp3 hybridization, but is
mostly in the sp2-hybridized state. It therefore does
not appear to be protonated, which would result in a tet-
rahedral configuration. Overall, these features suggest
that the intermediate structures predominantly adopt
a carbanion state. Consequently, the intermediates are
named 2-(a-hydroxy-isobutyl) thiamin diphosphate
(from KIV, referred to as VThDP), 2-(a-hydroxy-b-meth-
ylbutyl) thiamin diphosphate (from KMV, referred to as
MThDP), 2-(a-hydroxy-isopentyl) thiamin diphosphate
(from KIC, referred to as CThDP), and 2-(a-hydroxy-phe-
nyl)-thiamin diphosphate (from benzoylformate, referred
to as BThDP). Interestingly, when examining the elec-
tron density for a complex of Thermus thermophilus
E1b with CThDP (1.9 A˚ resolution, PDB entry 1UMD),
similar deviations from the enamine conformation are
apparent, but were not discussed (Nakai et al., 2004).
Because of the apparent nonplanar configuration, the
negative charge build-up at the Ca carbon can no longer
be delocalized across the thiazolium ring, because the
orbitals are not aligned. The resulting increase in carb-
anion character of the Ca carbon over the enamine state
may well be desirable, because it leads to an enhanced
nucleophilicity, which, in turn, is expected to increase
the reactivity during the subsequent reductive acylation
of lipoic acid.
Distortions in ThDP adducts have also been observed
in the crystal structure of the free-radical intermediate of
pyruvate:ferredoxin oxidoreductase (Chabriere et al.,
2001). This enzyme employs a radical mechanism for
the decarboxylation of pyruvate and is therefore mech-
anistically different from a-ketoacid dehydrogenases.
Yet, it further illustrates the plasticity of ThDP-derived
intermediates and indicates that such distortions could
be a feature of some thiamin-containing enzymes.
These distortions are potentially important for adjusting
the electronic properties of the cofactor and/or reaction
intermediates. It is not known whether E1 enzymes can
utilize a radical-based mechanism under certain circum-
stances. However, the bond lengths observed in the in-
termediates described here argue against the possibility
that a radical was trapped in the crystals. In contrast to
hE1b, a planar enamine/carbanion state was observed
in the crystal structure for transketolase in complex
with a,b-dihydroxyethyl-ThDP (Fiedler et al., 2002).
Both in hE1b and transketolase, no structural changes
occur in the substrate binding cavity, indicating thatthe active sites in these enzymes are preformed for ca-
talysis. It is therefore likely that the nature of the alkyl
moiety and its interactions with the surrounding resi-
dues determines the amount of deviation from planarity
at the Ca atom. It appears as if the structure of the sub-
strate binding cavity plays a specific role in generating
the exact electronic state of the decarboxylation inter-
mediate.
ThDP in the hE1b-Tyr113Phe Mutant
Appears Hyperactive
In order to assess the significance of the interactions be-
tween the Tyr113-a OH group and the thiazolium sulfur
further, we replaced Tyr113-a with phenylalanine. Nei-
ther substrate binding nor LBD affinity is significantly af-
fected by the Tyr113Phe-a mutation (Table 2). E1b-cat-
alyzed decarboxylation (Reaction 2) was measured in
the presence of 2,6-dichlorophenolindophenol (DCPIP),
which functions as an electron acceptor. The decarbox-
ylation was monitored by the reduction of absorbance at
600 nm. Wild-type E1b is a weak decarboxylase/dehy-
drogenase. In isolation, its kcat for decarboxylation is
equivalent to only 5% of that measured with a reconsti-
tuted BCKDC (Reaction 1) (Li et al., 2004). In the pres-
ence of an electron acceptor such as ferricyanide or
DCPIP, the intermediate of the E1b-catalyzed decarbox-
ylation is converted to a free acid (Das et al., 1961). Using
the spectrophotometric DCPIP assay, the Tyr113Phe-
a mutant kcat for the decarboxylation reaction is 171
min21, which is 14.4 times higher than that of the wild-
type (11.9 min21). The Km value is similar to that of the
wild-type (Table 2). These kcat values and their ratio
are in excellent agreement with those measured by us-
ing an alternative assay based on CO2 evolution in the
presence of DCPIP with [1-14C]KIV as a substrate (data
not shown). When assayed through CO2 evolution in
the absence of DCPIP, the Tyr113Phe-a mutant shows
a similar increase (11.2-fold) in E1b-catalyzed decarbox-
ylation activity over wild-type E1b, although the mea-
sured activities are less than those in the presence of
DCPIP (kcat 54.1 min
21 for the Tyr113Phe-a mutant
and 4.8 min21 for the wild-type). The increase in decar-
boxylation proficiency of the Tyr113Phe-a mutant com-
pared to the wild-type is thus independent of DCPIP.
Because substrate binding is not affected in the mutant,
these results suggest that the mutation specifically
affects the decarboxylation reaction and that its hyper-
activity is likely due to improved catalysis by the ThDP
in this variant.
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293Figure 5. Structure and 2Fo 2 Fc Electron
Density for Thiamin Thiazolone Diphosphate
in the Active Site of hE1b
(A and B) The electron density (shown in blue)
is contoured at 1.2 s. (A) The Tyr113Phe-a
mutant cocrystallized with ThDP, which was
subsequently oxidized to ThTDP, presum-
ably due to the hyperreactivity of ThDP. (B)
Wild-type hE1b cocrystallized with ThTDP.
The views and the color scheme are those
of Figure 2. Important interactions are shown
as dotted lines; water molecules are depicted
as red spheres.The increased activity of the Tyr113Phe-a mutant is
also reflected in the reductive acylation (Reaction 3).
For wild-type hE1b, the kcat at 30ºC is 10.2 s
21, which
is similar to that of E. coli E1p (Graham et al., 1989).
The Tyr113Phe-a mutant, on the other hand, has an al-
most 4-fold higher kcat (38.1 s
21) (Table 2). The reductive
acylation assay used [U-14C]KIV as the starting sub-
strate and is therefore linked to the decarboxylation re-
action. We speculate that the moderately higher reduc-
tive acylation activity of the Tyr113Phe-a variant is
a consequence of the faster turnover rate of the interme-
diate in the mutant.
When we incubated crystals of the Tyr113Phe-a mu-
tant with substrates, no reaction intermediate could be
observed in the electron density, as was the case with
wild-type hE1b. Instead, the ThDP cofactor was found
to be modified (Figure 5A). The electron density for the
modified ThDP shares the same characteristics as that
for thiamin thiazolone diphosphate (ThTDP), which con-
tains an oxygen atom covalently attached to the thiazo-
lium-C2 carbon, as observed in the E1p-ThTDP complex
(Arjunan et al., 2004). We confirmed this by soaking wild-
type hE1b crystals with ThTDP (Kluger et al., 1984) and
determining the crystal structure of the resulting hE1b-
ThTDP complex at 1.46 A˚ resolution (Figure 5B).
The phenylalanine side chain in the Tyr113Phe-a mu-
tant in the presence of ThTDP is predominantly in the S
conformation. By contrast, the side chain of Tyr113-a in
the wild-type hE1b-ThTDP complex is exclusively in the
P conformation because of a steric clash between the
thiazolone C2 oxygen and the Tyr113-a hydroxyl group.
This fact supports the notion that the main chain of the
residue at position 113 has a strong intrinsic preference
for the S conformation. The substrate binding cavity islarger in the Tyr113Phe-a mutant, but it is not large
enough to fully accommodate the substrate or decar-
boxylation product without being displaced into the P
conformation. However, the latter conformation cannot
be observed in the crystal of the Tyr113Phe-a mutant,
presumably due to the hyperreactivity and transient
nature of the intermediate.
The hE1b-Tyr113Phe Mutant Is Prone
to Paracatalytic Inactivation
The Tyr113Phe-a mutation apparently increases the re-
activity of the cofactor so that it can be easily oxidized.
The resulting ThTDP then slowly accumulates and can
be observed in our crystals. A similar irreversible deac-
tivation in the presence of substrate, termed ‘‘paracata-
lytic inactivation,’’ has previously been observed for
E1p, and strong evidence was presented that it was
due to the formation of ThTDP (Sumegi and Alkonyi,
1983). It was speculated that the oxidation was the result
of a side reaction after the decarboxylation intermediate
had been formed, and it appeared to be facilitated by the
presence of an extrinsic oxidizing agent, such as 2,6-di-
chlorophenolindophenol.
No extrinsic oxidizing compounds were added in our
experiments. We therefore hypothesized that molecular
oxygen present in solution was the source of the oxidiz-
ing agent. It is known that stable ylide/carbenes easily
react with oxygen (Enders and Balensiefer, 2004), but
the mechanism for this reaction is not known in detail.
To test our hypothesis, we incubated wild-type hE1b
and the Tyr113Phe-a mutant at room temperature in
the presence and absence of ThDP and oxygen and
monitored activity of the decarboxylation reaction over
a period of 24 hr. Oxygen was not directly applied to
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dictated by its solubility in equilibrium with atmospheric
oxygen. In order to reduce the oxygen concentration,
solutions were purged with argon. Three sets of samples
were prepared. Those samples in the absence of ThDP,
but in the presence of oxygen comprised the first set.
ThDP was supplied at the time the activity was deter-
mined. These experiments tested the intrinsic stability
of wild-type hE1b and the Tyr113Phe-amutant. The sec-
ond set comprised samples in the presence of both
ThDP and oxygen. No additional ThDP was added prior
to determining the decarboxylation activity. These ex-
periments tested the ability of oxygen to convert bound
ThDP to ThTDP. The last set included samples in the
presence of ThDP, but in the absence of oxygen.
As shown in Figure 6, wild-type hE1b loses less than
10% of its activity over a period of 24 hr. The degree of
reduction of activity is independent of whether ThDP
was present from the beginning or not and independent
of whether oxygen was excluded. Only the curve for wild-
type hE1b with ThDP present from the beginning is
shown. It is therefore most likely due to an inherent insta-
bility of the protein resulting in some fraction to denature
slowly over time and is not due to some fraction of bound
ThDP being converted to ThTDP by molecular oxygen
present in the solution. In contrast, when the Tyr113-
Phe-a mutant was incubated with ThDP and oxygen,
no activity was detectable after about 12 hr. When oxy-
gen is excluded, or when no ThDP is present from the be-
ginning, the loss of activity is comparable to wild-type
hE1b. These experiments clearly demonstrate that a re-
active oxygen species is able to oxidize ThDP in the
Tyr113Phe-a mutant, but not in the wild-type enzyme.
Paracatalytic Inactivation Is Conserved
in Pyruvate Dehydrogenase
The architecture of the active site is well preserved
among branched-chain a-ketoacid dehydrogenases
and pyruvate dehydrogenases. These enzymes may
therefore share many aspects of the catalytic mecha-
nism. To start exploring this issue, we have created
Figure 6. Relative Decarboxylation Activity of Wild-Type and Mutant
E1 Components of Human BCKDC and PDC in the Presence and Ab-
sence of Oxygen
Open diamonds, wild-type hE1b in the presence of oxygen; solid cir-
cles, hE1b Tyr113Phe-a in the presence of oxygen; open circles,
hE1b Tyr113Phe-a with oxygen excluded; solid squares, hE1p
Tyr89Phe-a in the presence of oxygen; open squares, hE1p Tyr89-
Phe-a with oxygen excluded.the Tyr89Phe-a mutant in human PDC E1 (hE1p), which
is equivalent to the Tyr113Phe-a mutant in hE1b. We
found a similar behavior as for hE1b, i.e., the hE1p
Tyr89Phe-amutant is more active in the decarboxylation
reaction by a factor of 12 than the wild-type (Table 2),
and it can easily be deactivated by molecular oxygen.
In the presence of oxygen, wild-type hE1p loses less
than 10% of its activity over a period of 24 hr (data not
shown). In contrast, the Tyr89Phe-a mutant is com-
pletely deactivated after about 5 hr, i.e., significantly
faster than hE1b, and, like hE1b, it retains its activity
when oxygen is excluded (Figure 6).
Taken together, the absence of the hydroxyl groups of
Tyr113-a in hE1b and Tyr89-a in hE1p, and, conse-
quently, the absence of interactions with ThDP corre-
lates with an increased turnover rate for these enzymes.
This observation in turn suggests that the presence of
the interactions in the wild-type enzyme effectively
downregulates the reactivity of the ThDP cofactor.
Interestingly, E1p from Mycobacterium genitalium
naturally has a phenylalanine instead of a tyrosine (Fig-
ure 4). It would be worthwhile to investigate whether par-
acatalytic inactivation is a serious side reaction in this
enzyme and if so, how the activity of ThDP is modulated.
Although awaiting further experimental characteriza-
tion, the following rationalization for the effects of
Tyr113-a in the P conformation can be offered at this
point. The interactions between Tyr113-a and ThDP
likely have both polar and nonpolar components. The
distance of 2.9 A˚ between the hydroxyl oxygen of
Tyr113-a and the sulfur clearly indicates a van der Waals
interaction. Furthermore, given the electronegativities of
the atoms and distances involved, it is likely that Tyr113-
a forms a short and strong hydrogen bond to the termi-
nal phosphate group of ThDP. This interaction imparts
a partial negative charge to the Tyr113-a hydroxyl oxy-
gen that can then interact with a partial positive charge
on the thiazolium sulfur. A similar polar interaction has
been postulated based on the observation of an intra-
molecular interaction between an internal oxygen and
the thiazolium sulfur in certain thiamin derivatives, e.g.,
in D,L-2-(a-hydroxybenzyl) thiamin chloride (Pletcher
et al., 1977). In addition, the hydrogen bond to the phos-
phate group would position the orbitals in the hydroxyl
oxygen such that, overall, the electron density at the
thiazolium sulfur is substantially increased. Such elec-
tronic distortions in the thiazolium ring likely have con-
sequences for the reactivity of the C2-carbon atom. In-
creasing the electron density on the thiazolium sulfur
should reduce the acidity of the C2 carbon (Kern et al.,
1997). Likewise, potential geometric distortions of the
thiazolium ring induced by the interactions with
Tyr113-a would result in a reduction of its aromaticity
and would thus further reduce the reactivity of the C2
carbon. The acidity decrease would then hamper the
formation of the ylide and reduce the nucleophilicity of
the ylide once it has been formed, thus explaining the in-
creased reactivity at the C2 carbon when the interac-
tions with Tyr113-a are not present.
The S/P Transition Leads to Remodeling
of the ‘‘Switch Turn’’
The S/P transition of Tyr113-a is accompanied by
a significant tilt in the main chain at this position
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tions in the Active Site of hE1b upon Decar-
boxylation of Benzoylformate, Induced by
the Side Chain Flip of Tyr113-a
(A and B) The structure in the absence of sub-
strate (carbon atoms and metal ions are in
gold) is superimposed onto the structure af-
ter substrate decarboxylation (carbon atoms
and metal ions are in cyan). (A) Close-up
view of the switch turn. ‘‘S’’ and ‘‘P,’’ respec-
tively, indicate the S and P conformation of
Tyr113-a. (B) Overall view of the switch turn
and the surrounding regions. Important elec-
trostatic and hydrogen bonding interactions
are shown as dotted lines; water molecules
and main chain atoms have been omitted
for clarity.(Figure 7A). The tilt is caused by the cramped disposition
of the tyrosine side chain against the ThDP. It triggers
a series of structural changes in both the backbone
and side chains in the region between residues 112-
a and 115-a and in the side chain conformations of sur-
rounding residues. Most notably, the carbonyl oxygen of
Gln112-a is rotated by about 100º (f/c =2139/68º in the
absence of substrate, f/c = 2115/127º in the presence
of intermediate). As a consequence, the side chain of
Gln112-a establishes hydrogen bonds with the main
chain nitrogen of Gly192-a and two oxygen atoms of
the a-phosphate group in ThDP (Figure 7B). The car-
boxyl group of Glu115-a rotates by about 45º with a sim-
ilar adjustment in the neighboring Glu92-a, His96-a, and
Arg220-a. Because Tyr113-a is located at the tip of
a tight turn connecting a b strand to an a helix, we will re-
fer to this region as the ‘‘switch turn.’’ The P conforma-
tion appears to be unfavorable relative to the S confor-
mation, because, in the absence of any substrate, the
S conformation is the predominant state. Inducing the
transition must cost some energy, which could be pro-
vided by substrate binding, or perhaps by a Brownian
ratchet mechanism. In the latter, it is assumed that
a small percentage of P state exists and that substrate
binds to this state but does not induce it.
The Switch Turn Is Crucial for LBD Binding
When Tyr113-a adopts the P conformation, the phos-
phorylation loop (residues 290-a to 313-a) containing
the two phosphorylation sites Ser292-a and Ser302-
a (Wynn et al., 2004) assumes a significantly more or-
dered structure than in the S conformation, presumably
due to the rearranged network of hydrogen bonds and
electrostatic interactions. The degree of order of the
phosphorylation loop correlates with LBD binding;LBD binding is abolished when the phosphorylation
loop region is disordered (this study and [Fries et al.,
2003; Li et al., 2004; Wynn et al., 2004]).
Determining whether the presence of a decarboxyl-
ation intermediate is directly responsible for an in-
creased LBD affinity requires the prevention of the sub-
sequent transfer of the alkyl chain from ThDP to the
lipoic acid. For this purpose, an enzymatically incompe-
tent P conformation with an intermediate present can be
generated by reacting hE1b with benzoylformate (see
above). We found that LBD binds to this intermediate
with an affinity that is 44 times higher than when no de-
carboxylation intermediate is present (Table 2). The
state of the active site is therefore indeed communi-
cated to the region where LBD binds. The thermody-
namic and kinetic consequences of this communication
mechanism in the context of the entire BCKDC machine
are not known in detail, yet these results suggest that it
may contribute to establishing, if not determining, the
order of events in hE1b.
Implications for the Reaction Mechanism in hE1b
Based on our results, we propose the following modifica-
tions to the general reaction mechanism of hE1b (Jordan,
2003; Schellenberger et al., 1997) (Figure 8). In the ab-
sence of substrate (Figure 8A), Tyr113-a exists predom-
inantly in the S conformation. ThDP adopts the typical,
activated V-shaped conformation. The thiazolium ring
has maximum aromaticity and therefore maximum re-
activity. When substrate binds (Figure 8B), Tyr113-a
switches into the P conformation, where it interacts
with the thiazolium ring. This interaction reduces the
reactivity of the C2 carbon, which would otherwise read-
ily react with a reactive oxygen species and inactivate
itself. Given the fact that enzymes often employ drastic
Structure
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tions Emphasizing the Role of Tyr113-a as
the Central RegulatoryConformational Switch
(A) Prior to substrate binding, the side chain
of Tyr113-a, the switch turn (indicated by
Q112jY113jR114), and the adjacent LBD
binding region are in the S conformation.
(B) Substrate binding displaces the Tyr113-a
side chain and forces it into the P conforma-
tion, where it establishes a hydrogen bond
to the terminal phosphate group in the ThDP
cofactor and additional interactions with the
sulfur in the thiazolium ring (dashed lines).
Simultaneously, the switch turn is remodeled,
whereupon the adjacent LBD binding region
adopts a higher-affinity state for LBD.
(C and D) After, or concomitant with, (C) de-
carboxylation, LBD binds to hE1b, followed
by (D) the transfer of an acyl moiety, derived
from the degradation of valine, leucine, or
isoleucine to lipoic acid (LA).
TZ, thiazolium ring; AP, aminopyrimidine ring;
B, general base.measures to increase the reactivity of cofactors and sub-
strates, it is ironic that the conserved mechanism that
ThDP-dependent enzymes use to activate the cofactor
may lead to a state where the cofactor is too reactive.
In this state, the thiazolium C2 carbon may have triplet
carbene character. Triplet carbenes with neighboring
heteroatoms, such as sulfur and nitrogen, are stable
and known to be excellent nucleophiles able to attack
carbonyl carbon atoms (Lee and Houk, 1997). Because
of their geometric characteristics, such an attack would
lead to the formation of a bond that is out of the thiazo-
lium plane, as observed for the decarboxylation reaction
intermediates in hE1b. Indeed, evidence is mounting that
carbenes may be involved in ThDP-catalyzed reactions
(Enders and Balensiefer, 2004). The nonplanar structure
of the intermediate suggests a carbanion state, and not
an enamine state or a resonance hybrid between these
two states as often indicated (Jordan, 2003). A carbanion
is expected to be more reactive in the following nucleo-
philic attack on lipoic acid in the reductive acylation
step. The transition from the S to the P state is accompa-
nied by a conformational change in the ‘‘switch turn’’
(residues 112-a to 114-a). This change leads to a rear-
rangement of the hydrogen bonding network that ex-
tends to the LBD binding region. As a result, the affinity
of hE1b for LBD increases by a factor of 44 (Figures
8B–8D). This switch can therefore be interpreted as a sig-
naling event for the LBD to bind and extract the acyl
chain from hE1b. Establishing this order would be impor-
tant to the overall activity of the BCKDC, because it is
very likely that LBD binding in the absence of a decarbox-
ylation intermediate would either prevent the binding of
an a-ketoacid substrate or prevent the decarboxylation
reaction from proceeding.
It is remarkable that these complicated regulatory
mechanisms are rooted in the subtle conformational
change of a single residue. Because the active site archi-
tecture is conserved across eukaryotic branched-chain
a-ketoacid dehydrogenases and pyruvate dehydroge-
nases, the pivotal Tyr113-a structural transition may
represent a common regulatory mechanism for these
key enzymes of general metabolism.Experimental Procedures
Enzymatic Assays
Decarboxylation Monitored by DCPIP Reduction
ThDP-mediated decarboxylation by the isolated E1b or E1p proteins
(Reaction 2) was assayed at 30ºC with KIV (for E1b proteins) or pyru-
vate (for E1p proteins) as substrate in the presence of the artificial
electron acceptor 2,6-dichlorophenolindophenol (DCPIP) by moni-
toring the reduction of the acceptor through its absorbance at 600
nm, as described previously (Lau et al., 1990) with minor modifica-
tions. The reaction mixture contained in 0.5 ml: 100 mM potassium
phosphate (pH 7.5), 1.0 mM ThDP, 2 mM magnesium chloride,
0.1 mM 2,6-dichlorophenolindophenol, and 15 mg of the E1 compo-
nent. The reaction mixture was preincubated at 30ºC for 6–8 min to
quench the preexisting reducing equivalents. The reaction at 30ºC
was started by adding varying concentrations of KIV. The DCPIP
assay is in good agreement with the decarboxylation assay that fol-
lows CO2 evolution (Chuang et al., 2000; Li et al., 2004). For the latter,
reactions were carried out both in the presence and in the absence
of DCPIP. For experiments in the absence of oxygen, all solutions
were exhaustively degassed and purged with argon.
Reductive Acylation
The assay for reductive acylation of lipoylated LBD (lip-LBD) cata-
lyzed by E1b (Reaction 3) was carried out as described previously
(Graham et al., 1989) with minor modifications. The reaction mixture
in a volume of 0.2 ml contained 50 mM potassium phosphate (pH 7.5),
1 mM ThDP, 2 mM magnesium chloride, 40 nM E1b (heterote-
tramers), and various concentrations of C terminally His6-tagged
lip-LBD. The reaction was initiated by the addition of 1.0 mM (final
concentration) [U-14C]KIV (specific activity 127,500 cpm/nmol). After
incubation at 30ºC for 1 min, the reaction was terminated by adding
trichloroacetic acid to a final concentration of 10% (w/v). The result-
ing precipitate was washed two times and resuspended in 100 ml of
8 M urea, and the radioactivity was quantitated in a scintillation
counter.
Binding of LBD to E1b Measured by Isothermal
Titration Calorimetry
Human E1b and lip-LBD, both C terminally His6 tagged, were dia-
lyzed exhaustively against the same reservoir of 50 mM Tris (pH
7.5), 50 mM potassium chloride, 10 mM b-mercaptoethanol, 5% (v/v)
glycerol, and 0.2 mM EDTA to remove bound magnesium ions and
ThDP. Immediately prior to isothermal titration calorimetry (ITC) mea-
surements, magnesium chloride and ThDP stock solutions were
added to both E1b and lip-LBD to a final concentration of 0.5 mM.
A total of 1.5 mM lip-LBD was added in 8 ml increments to a reaction
cell containing 1.8 ml of 75 mM human E1b (based on the ab hetero-
dimer), and the resulting heat changes were measured at 22ºC in a
MicroCal (Northampton, MA) VP-ITC microcalorimeter. Binding
isotherms derived from the resulting heat changes were used to
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equation:DGº =2RTInKa, whereR is the gas constant,T the absolute
temperature, and Ka the association constant. From the binding iso-
therms, the number of binding sites (n) was obtained, and changes in
enthalpy (DHº) and entropy (DSº) were calculated according to the
equation: DGº = DHº2 TDSº. Curve fitting and the derivation of ther-
modynamic parameters were carried out with the ORIGIN software
package provided by MicroCal. The concentrations of human E1b
dimers and lip-LBD monomers were determined by UV absorption
spectroscopy at 280 nm by using calculated extinction coefficients
(in mg21ml cm21) of 1.14 for the former and 1.07 for the latter.
X-Ray Crystallography of Wild-Type and Mutant hE1b Proteins
Crystals of wild-type and mutant human E1b proteins were grown in
the absence and presence of substrates at 22ºC via the vapor-diffu-
sion method as described previously (Wynn et al., 2003). Crystals
exhibited the symmetry of space group P3121 with cell parameters
of approximately 145 3 145 3 69 A˚, contained one ab0 heterodimer
per asymmetric unit, and diffracted X-rays to a minimum Bragg
spacing, dmin, of 1.8–2.2 A˚. In some cases, a second crystal form
was used that also contained a 40 amino acid peptide derived
from the ‘‘subunit binding domain’’ (SBD) of hE2b (Wynn et al.,
2004). For X-ray diffraction experiments, crystals were flash cooled
in liquid propane and kept at about 100 K during data collection at
beamlines 19ID and 19BM (Advanced Photon Source [APS], Ar-
gonne National Laboratory, Argonne, IL). Data sets were processed
with the HKL2000 package (Otwinowski and Minor, 1997).
All structures were determined by difference Fourier techniques
using a previously determined hE1b wild-type structure (PDB code
1OLS) as the initial model. Refinement of the models was carried
out with the program Refmac5 (Murshudov, 1997) of the CCP4 pack-
age (CCP4, 1994) with a random subset of all data set aside for the
calculation of Rfree factors. Manual adjustments to the models
were carried out with the program O (Jones et al., 1991).
The electron density clearly showed the presence of glycerol mol-
ecules and chloride ions in some of the crystal structures. After the
refinement of the protein portions was complete, solvent molecules
were added where chemically reasonable. Single residues with poor
corresponding electron densities were included in the model when
they were flanked by other residues with well-defined electron den-
sity. For crystals containing the hE1b-SBD complex, strong electron
density was visible for the SBD peptide, but it was not included in the
model. SBD binds to the C termini of the hE1bb subunits. The binding
site is so close to the internal 2-fold symmetry axis in hE1b that only
one SBD molecule can be accommodated per complete tetramer.
Because of this feature, the electron density for SBD is averaged
and overlapped and did not allow unambiguous tracing. Models for
the reaction intermediates were included only at the very end of the
modeling/refinement process. Ramachandran analysis shows that,
generally, more than 99% of all residues are in allowed regions. Of
those that are in disallowed regions, Ile226-a and Arg255-b have
well-defined electron density. The remaining residues are in loop re-
gions with weak accompanying electron density. Data collection and
refinement statistics are listed in Table 1.
The appearance of the electron density suggested that the thiazo-
lium ring in the reaction intermediates was not entirely planar. Least-
squares planes and rms deviations were calculated with the program
moleman2 (Kleywegt, 2000) for all atoms that are supposed to lie on
the same plane (thiazolium ring atom and directly bonded atoms)
when one assumes that the thiazolium ring is entirely aromatic and
therefore planar (Table 1). Coordinate errors were calculated in the
form of the diffraction-component-index (DPI) according to Cruick-
shank (1999). Because of the limited resolution, it is not possible to ac-
curately calculate experimental errors for individual atomic positions.
Expression and Purification of Human hE1p
Recombinant His6-tagged human E1p (wild-type and Tyr89Phe-
amutant) was expressed in Escherichia coli strain BL-21 by cotrans-
formation of the pGroESL plasmid overproducing chaperonins
GroEL and GroES as described previously (Wynn et al., 1992,
2001). Wild-type and mutant His6-tagged E1p proteins were isolated
from cell lysates by using a Ni2+-NTA-derivatized Sepharose CL-6B
column (Qiagen) as described previously (Wynn et al., 1998). E1p
proteins were then applied to a Resource Q column (1.75 3 10 cm)
in 50 mM potassium phosphate (pH 7.5), 10 mM KCl, 5% (v/v) glyc-erol, and 10 mM b-mercaptoethanol, eluted with a linear salt gradient
from 10–500 mM KCl in the same buffer, and then further purified by
size-exclusion chromatography (Superdex-200, Amersham Phar-
macia Biotech) in 50 mM potassium phosphate (pH 7.5), 250 mM
KCl, 5% (v/v) glycerol, 20 mM b-mercaptoethanol, 1 mM benzami-
dine, and 0.5 mM phenylmethylsulfonyl fluoride. E1p activity during
purification was assayed spectrophotometrically by reconstitution
with E2p/E3 binding protein and E3 (Hiromasa et al., 2004). Protein
concentrations were determined by UV absorption at 280 nm by
using a molar extinction coefficient of 0.94 mg21ml cm21 for the
a2b2 heterotetramer (Kato et al., 2005).
Supplemental Data
Supplemental Data including a figure showing the structures and
electron densities for decarboxylation products of 2-(a-hydroxy-
isobutyl)-ThDP (VThDP), the intermediate from a-ketoisovalerate
(KIV), and 2-(a-hydroxy-b-methylbutyl)-ThDP (MThDP), the interme-
diate from a-keto-b-methylvalerate (KMV), are available at http://
www.structure.org/cgi/content/full/14/2/287/DC1/.
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